Bicycle Therapeutics PLC
BCYC· Nasdaq
Released Feb 25, 2025, before the open
10-K filed Feb 25, 2025, 56 days after period end · 0001558370-25-001438
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $3.71M | $5.33M | $3.19M | $3.77M |
| Net Income | -$51.85M |
Bicycle Therapeutics PLC · CIK 1761612 · Engraved from SEC EDGAR
| -$49.10M |
| -$29.98M |
| -$18.04M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.